119 related articles for article (PubMed ID: 33895924)
21. Some aspects of the initiation of protein synthesis in Crithidia fasciculata and Tetrahymena pyriformis.
Kidder GW; Dewey VC
Comp Biochem Physiol B; 1975 Dec; 52(4):537-9. PubMed ID: 812632
[No Abstract] [Full Text] [Related]
22. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
23. The Product of Matrix Metalloproteinase Cleavage of Doxorubicin Conjugate for Anticancer Drug Delivery: Calorimetric, Spectroscopic, and Molecular Dynamics Studies on Peptide-Doxorubicin Binding to DNA.
Butowska K; Żamojć K; Kogut M; Kozak W; Wyrzykowski D; Wiczk W; Czub J; Piosik J; Rak J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967212
[TBL] [Abstract][Full Text] [Related]
24. Structure-toxicity relationships for the effects of N- and N,N'-alkyl thioureas to Tetrahymena pyriformis.
Schultz TW; Tucker VA
Bull Environ Contam Toxicol; 2003 Jun; 70(6):1251-8. PubMed ID: 12756468
[No Abstract] [Full Text] [Related]
25. Microplate technique for screening and assessing cytotoxicity of xenobiotics with Tetrahymena pyriformis.
Sauvant MP; Pepin D; Bohatier J; Groliere CA
Ecotoxicol Environ Saf; 1995 Nov; 32(2):159-65. PubMed ID: 8575361
[TBL] [Abstract][Full Text] [Related]
26. The effect of tinidazole on several ciliates.
Alonso P
Chemotherapy; 1979; 25(1):40-7. PubMed ID: 105840
[TBL] [Abstract][Full Text] [Related]
27. Characterization of chemotactic ability of peptides containing N-formyl-methionyl residues in Tetrahymena fMLP as a targeting ligand.
Kohidai L; Török K; Illyés E; Tamási J; Sebestyén F; Láng O; Csaba G; Hudecz F
Cell Biol Int; 2003; 27(8):695-700. PubMed ID: 12867161
[TBL] [Abstract][Full Text] [Related]
28. Identification of a multidrug resistance-like system in Tetrahymena pyriformis: evidence for a new detoxication mechanism in freshwater ciliates.
Bamdad M; Brousseau P; Denizeau F
FEBS Lett; 1999 Aug; 456(3):389-93. PubMed ID: 10462050
[TBL] [Abstract][Full Text] [Related]
29. ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice.
Zhang N; Xia Y; Zou Y; Yang W; Zhang J; Zhong Z; Meng F
Mol Pharm; 2017 Aug; 14(8):2538-2547. PubMed ID: 28005375
[TBL] [Abstract][Full Text] [Related]
30. Chemotaxis of the unicellular green alga Dunaliella salina and the ciliated Tetrahymena pyriformis--effects of glycine, lysine, and alanine, and their oligopeptides.
Kóhidai L; Kovács P; Csaba G
Biosci Rep; 1996 Dec; 16(6):467-76. PubMed ID: 9062698
[TBL] [Abstract][Full Text] [Related]
31. Galactoxyloglucan-doxorubicin nanoparticles exerts superior cytotoxic effects on cancer cells-A mechanistic and in silico approach.
Joseph MM; G A; T K M; T T S
Int J Biol Macromol; 2016 Nov; 92():20-29. PubMed ID: 27373427
[TBL] [Abstract][Full Text] [Related]
32. Prediction of chemical toxicity to Tetrahymena pyriformis with four-descriptor models.
Yu X
Ecotoxicol Environ Saf; 2020 Mar; 190():110146. PubMed ID: 31923753
[TBL] [Abstract][Full Text] [Related]
33. PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity.
Kohay H; Sarisozen C; Sawant R; Jhaveri A; Torchilin VP; Mishael YG
Acta Biomater; 2017 Jun; 55():443-454. PubMed ID: 28400314
[TBL] [Abstract][Full Text] [Related]
34. Testing for the toxicity of chemicals with Tetrahymena pyriformis.
Yoshioka Y; Ose Y; Sato T
Sci Total Environ; 1985 May; 43(1-2):149-57. PubMed ID: 3925549
[TBL] [Abstract][Full Text] [Related]
35. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
Ganapathi R; Grabowski D
Biochem Pharmacol; 1988 Jan; 37(2):185-93. PubMed ID: 3342075
[TBL] [Abstract][Full Text] [Related]
37. [The effect of dichlorvos and metathion on selected enzymes of the amoeba Tetrahymena pyriformis].
Nistiar F; Hrusovský J; Mojzis J
Vet Med (Praha); 1985 Jul; 30(7):443-7. PubMed ID: 3927568
[TBL] [Abstract][Full Text] [Related]
38. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
39. Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer.
Sheng Y; You Y; Chen Y
Int J Pharm; 2016 Oct; 512(1):1-13. PubMed ID: 27521706
[TBL] [Abstract][Full Text] [Related]
40. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
